Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Recurrence × Nivolumab × Clear all

Phase

Status

Completed 11 Recruiting 4 Active not recruiting 4 Terminated 2 Withdrawn 1 Unknown 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Malignant Ascites 1 Hodgkin Disease 1 Glioblastoma 1 Astrocytoma 1

Interventions

fludarabine 1 Nivolumab 1 Cyclophosphamide 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06931613 2025-04-17

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

St. Petersburg State Pavlov Medical University

Phase 2 Enrolling by invitation

Hodgkin Disease, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡